Limitations of the PRODIGE 7 trial
- PMID: 33932375
- DOI: 10.1016/S1470-2045(21)00096-6
Limitations of the PRODIGE 7 trial
Conflict of interest statement
PC reports co-authoring previously published articles with some authors of the PRODIGE 7 trial.
Comment in
-
Limitations of the PRODIGE 7 trial - Authors' reply.Lancet Oncol. 2021 May;22(5):e179-e180. doi: 10.1016/S1470-2045(21)00192-3. Lancet Oncol. 2021. PMID: 33932377 No abstract available.
Comment on
-
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial.Lancet Oncol. 2021 Feb;22(2):256-266. doi: 10.1016/S1470-2045(20)30599-4. Epub 2021 Jan 18. Lancet Oncol. 2021. PMID: 33476595 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical